Veracyte, Inc.: Stephens cuts target price to $40 from $55
VCYT•Stephens cut its target price for Veracyte to $40 from $55.
Related News
Gossamer Bio: Wedbush cuts target price to $32 from $80
GOSS•
Dollar firms as hot inflation, hawkish Fed talk lift rate-hike bets
TLT•
Israel's InMode Q3 revenue slightly beats estimates on Asia growth
INMD•
Flywire Corporation: Truist Securities raises target price to $23 from $19
FLYW•
Merlin wins $500,000 U.S. Africa Command contract for autonomous casualty evacuation demo
MRLN•